[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
Identifieur interne : 000386 ( PubMed/Corpus ); précédent : 000385; suivant : 000387[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
Auteurs : Pierre Grandgenevre ; Frédérique Warembourg ; Nicolas Carrière ; Alexandra Vaillant ; Luc Defebvre ; Guillaume VaivaSource :
- Presse medicale (Paris, France : 1983) [ 2213-0276 ] ; 2015.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (adverse effects), Caregivers (psychology), Decision Making, Disruptive, Impulse Control, and Conduct Disorders (chemically induced), Disruptive, Impulse Control, and Conduct Disorders (diagnosis), Disruptive, Impulse Control, and Conduct Disorders (therapy), Female, Humans, Interviews as Topic, Male, Middle Aged, Parkinson Disease (therapy), Sexual Behavior (drug effects), Sexual Dysfunction, Physiological (chemically induced), Sexual Dysfunction, Physiological (diagnosis), Sexual Dysfunction, Physiological (therapy), Spouses (psychology).
- MESH :
- chemical , adverse effects : Antiparkinson Agents.
- chemically induced : Disruptive, Impulse Control, and Conduct Disorders, Sexual Dysfunction, Physiological.
- diagnosis : Disruptive, Impulse Control, and Conduct Disorders, Sexual Dysfunction, Physiological.
- drug effects : Sexual Behavior.
- psychology : Caregivers, Spouses.
- therapy : Disruptive, Impulse Control, and Conduct Disorders, Parkinson Disease, Sexual Dysfunction, Physiological.
- Aged, Decision Making, Female, Humans, Interviews as Topic, Male, Middle Aged.
Abstract
To improve the management of hypersexuality caused by antiparkinsonian treatment and its psychopathological implications in patients with Parkinson's disease (PD). If hypersexuality is a classic form of impulse control disorder (ICD) observed in PD, its rate is certainly underestimated.
DOI: 10.1016/j.lpm.2014.06.037
PubMed: 25578547
Links to Exploration step
pubmed:25578547Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].</title><author><name sortKey="Grandgenevre, Pierre" sort="Grandgenevre, Pierre" uniqKey="Grandgenevre P" first="Pierre" last="Grandgenevre">Pierre Grandgenevre</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France. Electronic address: Pierre.Grandgenevre@CHRU-LILLE.FR.</nlm:affiliation></affiliation></author><author><name sortKey="Warembourg, Frederique" sort="Warembourg, Frederique" uniqKey="Warembourg F" first="Frédérique" last="Warembourg">Frédérique Warembourg</name><affiliation><nlm:affiliation>CHRU de Lille, service des urgences, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Carriere, Nicolas" sort="Carriere, Nicolas" uniqKey="Carriere N" first="Nicolas" last="Carrière">Nicolas Carrière</name><affiliation><nlm:affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillant, Alexandra" sort="Vaillant, Alexandra" uniqKey="Vaillant A" first="Alexandra" last="Vaillant">Alexandra Vaillant</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><nlm:affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaiva, Guillaume" sort="Vaiva, Guillaume" uniqKey="Vaiva G" first="Guillaume" last="Vaiva">Guillaume Vaiva</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25578547</idno><idno type="pmid">25578547</idno><idno type="doi">10.1016/j.lpm.2014.06.037</idno><idno type="wicri:Area/PubMed/Corpus">000386</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000386</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].</title><author><name sortKey="Grandgenevre, Pierre" sort="Grandgenevre, Pierre" uniqKey="Grandgenevre P" first="Pierre" last="Grandgenevre">Pierre Grandgenevre</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France. Electronic address: Pierre.Grandgenevre@CHRU-LILLE.FR.</nlm:affiliation></affiliation></author><author><name sortKey="Warembourg, Frederique" sort="Warembourg, Frederique" uniqKey="Warembourg F" first="Frédérique" last="Warembourg">Frédérique Warembourg</name><affiliation><nlm:affiliation>CHRU de Lille, service des urgences, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Carriere, Nicolas" sort="Carriere, Nicolas" uniqKey="Carriere N" first="Nicolas" last="Carrière">Nicolas Carrière</name><affiliation><nlm:affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillant, Alexandra" sort="Vaillant, Alexandra" uniqKey="Vaillant A" first="Alexandra" last="Vaillant">Alexandra Vaillant</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><nlm:affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaiva, Guillaume" sort="Vaiva, Guillaume" uniqKey="Vaiva G" first="Guillaume" last="Vaiva">Guillaume Vaiva</name><affiliation><nlm:affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Presse medicale (Paris, France : 1983)</title><idno type="eISSN">2213-0276</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (adverse effects)</term><term>Caregivers (psychology)</term><term>Decision Making</term><term>Disruptive, Impulse Control, and Conduct Disorders (chemically induced)</term><term>Disruptive, Impulse Control, and Conduct Disorders (diagnosis)</term><term>Disruptive, Impulse Control, and Conduct Disorders (therapy)</term><term>Female</term><term>Humans</term><term>Interviews as Topic</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (therapy)</term><term>Sexual Behavior (drug effects)</term><term>Sexual Dysfunction, Physiological (chemically induced)</term><term>Sexual Dysfunction, Physiological (diagnosis)</term><term>Sexual Dysfunction, Physiological (therapy)</term><term>Spouses (psychology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term><term>Sexual Dysfunction, Physiological</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term><term>Sexual Dysfunction, Physiological</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Sexual Behavior</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Caregivers</term><term>Spouses</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Disruptive, Impulse Control, and Conduct Disorders</term><term>Parkinson Disease</term><term>Sexual Dysfunction, Physiological</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Decision Making</term><term>Female</term><term>Humans</term><term>Interviews as Topic</term><term>Male</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To improve the management of hypersexuality caused by antiparkinsonian treatment and its psychopathological implications in patients with Parkinson's disease (PD). If hypersexuality is a classic form of impulse control disorder (ICD) observed in PD, its rate is certainly underestimated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25578547</PMID><DateCreated><Year>2015</Year><Month>03</Month><Day>13</Day></DateCreated><DateCompleted><Year>2015</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-0276</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Presse medicale (Paris, France : 1983)</Title><ISOAbbreviation>Presse Med</ISOAbbreviation></Journal><ArticleTitle>[Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].</ArticleTitle><Pagination><MedlinePgn>e51-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lpm.2014.06.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0755-4982(14)00600-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To improve the management of hypersexuality caused by antiparkinsonian treatment and its psychopathological implications in patients with Parkinson's disease (PD). If hypersexuality is a classic form of impulse control disorder (ICD) observed in PD, its rate is certainly underestimated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We have proposed to meet patients with Parkinson's disease, referred by the neurology department of Lille University Hospital, for detection or suspicion of hypersexuality, in the presence of their spouse. The session consisted of an interview conducted by our psychiatry team. This evaluation was conducted between January 1 and August 31, 2011. Nine patients were referred to our service, 7 agreed to meet us, 6 of them with their spouse.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An interview in the presence of the spouse has improved hypersexuality screening and information given to the patient and his close contacts regarding the side effects of treatment, and particularly the occurrence of hypersexuality. It also highlighted the various expressions of these behavioral changes, often minimized by patients, as spouses had great difficulty dealing with this. It helped them to improve verbal communication and, therefore, to be more informative concerning sexual behavior changes in connection with the treatment and its management. Finally, it has enabled improved support for secondary consequences of this impulse control disorder, such as guilt, jealousy or shame. Our interest has also focused on the impact of this hypersexuality on patients' families. Among the six sets partners, four had symptoms requiring specific psychiatric care: depression, suicidal intention or post-traumatic stress disorder.</AbstractText><AbstractText Label="PERSPECTIVE" NlmCategory="CONCLUSIONS">Hypersexuality seems underestimated in patients receiving antiparkinsonian treatment. This underestimation is probably linked to some defense mechanisms such as denial or minimization, but also to the feelings generated by these behavioral problems, such as shame or guilt. On the other hand, some patients do not experience stress related behavioral changes (even though the family may complain). Systematic partner interview could be a solution to improving this screening.</AbstractText><CopyrightInformation>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grandgenevre</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France. Electronic address: Pierre.Grandgenevre@CHRU-LILLE.FR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warembourg</LastName><ForeName>Frédérique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHRU de Lille, service des urgences, 59037 Lille cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrière</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaillant</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defebvre</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France; CHRU de Lille, service de neurologie et pathologie du mouvement, 59037 Lille cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaiva</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CHRU de Lille, hôpital Fontan, service de psychiatrie adulte, 59037 Lille cedex, France; Université du Droit et de la Santé de Lille, EA 4559, 59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Prise en charge de l'hypersexualité dans la maladie de Parkinson. Intérêt de la présence de l'entourage lors de l'évaluation médicale.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Presse Med</MedlineTA><NlmUniqueID>8302490</NlmUniqueID><ISSNLinking>0755-4982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="N">Caregivers</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007174" MajorTopicYN="N">Disruptive, Impulse Control, and Conduct Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012725" MajorTopicYN="N">Sexual Behavior</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012735" MajorTopicYN="N">Sexual Dysfunction, Physiological</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018454" MajorTopicYN="Y">Spouses</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>05</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25578547</ArticleId><ArticleId IdType="pii">S0755-4982(14)00600-9</ArticleId><ArticleId IdType="doi">10.1016/j.lpm.2014.06.037</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000386 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000386 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25578547
|texte= [Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25578547" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |